Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Assessment of the activity of the immune system in patients with inflammatory bowel diseases and asymptomatic COVID-19
Publication Year: 2024 Source: Prz Gastroenterol PMID: 38571543 DOI: 10.5114/pg.2023.124281
INTRODUCTION: Although the phenomenon of cytokine storm is well described in patients with severe COVID-19, little is known about the role of the immune system in asymptomatic patients, especially in the group with autoimmune diseases, such as inflammatory bowel disease (IBD). AIM: To assess the stimulation of the immune system …
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
Publication Year: 2024 Source: Autoimmune Dis PMID: 38571561 DOI: 10.1155/2024/6627035
BACKGROUND: The pandemic situation of the novel coronavirus (severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) and its associated disease (coronavirus disease 2019 (COVID-19)) represents a challenging condition with a plethora of aspects. The course of COVID-19 in patients with immune-mediated inflammatory diseases (IMID) such as inflammatory bowel disease (IBD) and …
Harnessing the power of resistant starch: a narrative review of its health impact and processing challenges
Publication Year: 2024 Source: Front Nutr PMID: 38571748
No Abstract
The Efficacy and Safety of Biologics in Treating Ankylosing Spondylitis and Their Impact on Quality of Life and Comorbidities: A Literature Review
Publication Year: 2024 Source: Cureus PMID: 38571822 DOI: 10.7759/cureus.55459
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects the axial skeleton, causing intense pain, progressive joint destruction, and a gradual reduction in physical function. Additionally, AS can result in extra-musculoskeletal manifestations including inflammatory bowel disease (IBD), psoriasis, and acute anterior uveitis (AAU) affecting patients' quality of life (QoL). …
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation
Publication Year: 2024 Source: Rheumatol Immunol Res PMID: 38571927 DOI: 10.1515/rir-2024-0006
BACKGROUND AND OBJECTIVES: Psoriasis (PsO) and psoriatic arthritis (PsA) are often undertreated and require a multidisciplinary approach. In recent years, patent expiration has allowed the introduction of tumor necrosis factor inhibitor (anti-TNF) biosimilars, which have stimulated a significant increase in the use of biological therapies. This article reports the findings …
The effect of anti-TNF drugs on the intestinal microbiota in patients with spondyloarthritis, rheumatoid arthritis, and inflammatory bowel diseases
Publication Year: 2024 Source: Rheumatol Immunol Res PMID: 38571933 DOI: 10.1515/rir-2024-0003
Spondyloarthritis (SpA), rheumatoid arthritis (RA), and inflammatory bowel diseases (IBD) are chronic inflammatory autoimmune diseases that are associated with alterations in the composition of the intestinal microbiota (i.e., dysbiosis). For SpA and RA, a gut-joint-enthesis axis is hypothesized and recent data suggests that dysbiosis may contribute directly to initiating and …
Leaky gut, circulating immune complexes, arthralgia, and arthritis in IBD: coincidence or inevitability?
Publication Year: 2024 Source: Front Immunol PMID: 38571963 DOI: 10.3389/fimmu.2024.1347901
Most host-microbiota interactions occur within the intestinal barrier, which is essential for separating the intestinal epithelium from toxins, microorganisms, and antigens in the gut lumen. Gut inflammation allows pathogenic bacteria to enter the blood stream, forming immune complexes which may deposit on organs. Despite increased circulating immune complexes (CICs) in …
Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta-analysis of randomized controlled trials
Publication Year: 2024 Source: JGH Open PMID: 38572328
No Abstract
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study
Publication Year: 2024 Source: J Crohns Colitis PMID: 38572716
No Abstract
Protective effects of sinomenine against dextran sulfate sodium-induced ulcerative colitis in rats via alteration of HO-1/Nrf2 and inflammatory pathway
Publication Year: 2024 Source: Inflammopharmacology PMID: 38573363 DOI: 10.1007/s10787-024-01455-6
BACKGROUND: Dextran Sulfate Sodium (DSS) induces ulcerative colitis (UC), a type of inflammatory bowel disease (IBD) that leads to inflammation, swelling, and ulcers in the large intestine. The aim of this experimental study is to examine how sinomenine, a plant-derived alkaloid, can prevent or reduce the damage caused by DSS …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide